The Safety of Soy Leghemoglobin Protein Preparation Derived from Pichia pastoris Expressing a Soy Leghemoglobin Gene from Glycine max: In Vitro and In Vivo Studies
Table 14
Summary of mean body weights in 90 day study (g) recovery phasea,.
LegH dose levels (study day)
Group 1 (0 ppm)
Group 4 (90,000 ppm)
M
F
M
F
91
Mean ± SD
644.4 ± 54.1
338.4 ± 30.8
624.6 ± 62.9
322 ± 27.6
98
Mean ± SD
656.8 ± 54
346.6 ± 32.1
637.6 ± 62.6
332.8 ± 29.6
105
Mean ± SD
665.6 ± 56.2
351.6 ± 34.2
645.2 ± 61.0
335.6 ± 29
112
Mean ± SD
678.8 ± 55.3
358.8 ± 32.9
656.8 ± 61.6
343.6 ± 32.7
119
Mean ± SD
688.6 ± 55.9
367.8 ± 41
668.4 ± 61.9
352.2 ± 39.3
aOne-way repeat ANOVA and Dunnett test. N = 5/sex/group. M: male; F: female; LegH: leghemoglobin protein; SD: standard deviation.
